|
|
| (2 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| | | #REDIRECT [[Cilostazol#Overdosage]] |
| __NOTOC__
| |
| {{Cilostazol}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
| | |
| ==Overdosage==
| |
| | |
| Information on acute overdosage with PLETAL in humans is limited. The signs and symptoms of an acute overdose can be anticipated to be those of excessive pharmacologic effect: severe headache, diarrhea, hypotension, tachycardia, and possibly cardiac arrhythmias. The patient should be carefully observed and given supportive treatment. Since cilostazol is highly protein-bound, it is unlikely that it can be efficiently removed by hemodialysis or peritoneal dialysis.
| |
| The oral LD50 of cilostazol is > 5.0 g/kg in mice and rats and > 2.0 g/kg in dogs.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PLETAL (CILOSTAZOL) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d75b58-bafb-4440-b8d7-4f4079c08b0b | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Drugs]]
| |